WTC
JAZZ icon

WhitTier Trust Company’s Jazz Pharmaceuticals JAZZ Stock Holding History

WhitTier Trust Company’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$106 – 1396
2025
Q2 		$106 Hold
1
– – ﹤0.01% 1425
2025
Q1 		$124 Hold
1
– – ﹤0.01% 1403
2024
Q4 		$123 Hold
1
– – ﹤0.01% 1329
2024
Q3 		$111 Buy
+1
New +$110 ﹤0.01% 1327
2024
Q2 		– Sell
-80
Closed -$9.63K – 1289
2024
Q1 		$9.63K Hold
80
– – ﹤0.01% 955
2023
Q4 		$9.84K Buy
+80
New +$9.98K ﹤0.01% 947
2023
Q1 		– Sell
-12
Closed -$1.91K – 1189
2022
Q4 		$1.91K Buy
+12
New +$1.76K ﹤0.01% 1101

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

WhitTier Trust Company's JAZZ Position: Q3 2025 in Review

WhitTier Trust Company sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2025, closing a stake of 1 share — an estimated $106 sold.

WhitTier Trust Company first reported a position in JAZZ in Q4 2022 and held it in 7 quarters. The position peaked at $9.84K in Q4 2023. 503 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • WhitTier Trust Company reported no remaining Jazz Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • WhitTier Trust Company sold 1 Jazz Pharmaceuticals share in Q3 2025, an estimated $106.
  • WhitTier Trust Company first reported a position in Jazz Pharmaceuticals in Q4 2022 and held it in 7 quarters.
  • WhitTier Trust Company's Jazz Pharmaceuticals position peaked at $9.84K in Q4 2023.
  • 503 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on WhitTier Trust Company's 13F filing for Q3 2025, filed 31 Oct 2025.